Immunophenotypically, atypical CLL is characterized by lack of expression of one or fewer surface antigens, most commonly CD5 and CD23, and it does not meet the criteria for diagnosis of any other B-cell lymphomas. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.